The serum creatinine levels of the renal transplant recipients at 4 days post-transplantation had no significant difference between the group of modified combined liver-kidney retrieval and the group of retrieval of kidneys alone(157μmol/L vs. 165μmol/L,P>0.05).
[Methods] 120 cadaveric renal transplant recipients were randomly divided into 3 groups, receiving MMF 2.0 g/d , CsA and Pred (group A), MMF 1.5 g/d, CsA and Pred (group B) and Azathioprine (Aza) 100 mg/d, CsA and Pred(group C)respectively.
Methods Percentage of T_H1/T_H2/T_H3 and Tc1/Tc2 cells and the ratio of CD4/CD8 was examined by flow cytometry in 24 cases of renal transplantation recipients while analyzing those from healthy volunteers(n=10 individuals).
Conclusion Detection of serum CMV antibody and CMV DNA in renal transplantation recipients is helpful for the diagnosis of CMV infection and CMV disease and is of great importance in the treatment of CMV disease after kidney transplantation.
Ofloxacin in the treatment of urinary tract infection in renal transplant recipients
Forty-two renal transplant recipients suffering from complicated urinary tract infection (UTI) were treated orally with ofloxacin.
Laboratory diagnosis of 24 cases of human cytomegalovirus (HCMV) infection in patients with the acquired immunodeficiency syndrome, renal transplant recipients and premature infants was achieved.
Improvement of serological diagnosis of human cytomegalovirus infection in renal transplant recipients by testing for specific i
Four of them had been isolated from renal transplant recipients.Listeria monocytogenes was neither detected in food samples of the renal transplantation ward, nor in stool specimens obtained from the ward staff.
The kinetics of human cytomegalovirus (HCMV)-specific immunoglobulin E (IgE), M (IgM), A (IgA) and G (IgG) were studied in 421 sera obtained from 19 renal allograft recipients by enzyme-linked immunosorbent assay (ELISA).
As shown by the present study, specific IgE proved to be a more reliable serologic marker than IgM and IgA for the serologic detection of HCMV infection in renal allograft recipients.
Such changes may be responsible for the increased risk of infectious complications seen in older renal allograft recipients.
In a period of 10 months neopterin in serum and urine was determined by radioimmunoassay in 33 renal allograft recipients treated with cyclosporin A.
Serial flow cytometric determinations of lymphocyte subsets in renal allograft recipients may be helpful in some cases although rejection episodes could not be predicted in the individual patient.